HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides.

HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides.

Current candidate vaccines fail to protect primates against challenge with human immunodeficiency virus (HIV) in the presence of antibody responses; this underlines the importance of studying cell-mediated immunity to HIV and identifying specific epitopes that stimulate cytotoxic T lymphocytes (CTL)...

Description complète

Détails bibliographiques
Auteurs principaux:	Nixon, D, Townsend, A, Elvin, J, Rizza, C, Gallwey, J, Mcmichael, A
Format:	Journal article
Langue:	English
Publié:	1988

Documents similaires

HIV-gag-specific cytotoxic T lymphocytes.
par: Nixon, D, et autres
Publié: (1989)

The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.
par: Townsend, A, et autres
Publié: (1986)

The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides
par: Townsend, A, et autres
Publié: (1986)

The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. 1986.
par: Townsend, A, et autres
Publié: (2006)

Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro.
par: Dorrell, L, et autres
Publié: (2000)

High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals.
par: Gotch, F, et autres
Publié: (1990)

Use of synthetic peptides of influenza nucleoprotein to define epitopes recognized by class I-restricted cytotoxic T lymphocytes.
par: Bastin, J, et autres
Publié: (1987)

The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides (reprinted from Cell, vol. 44, pg. 959-968, yr. 1986)
par: Townsend, A, et autres
Publié: (2006)

Cytotoxic T-cell response to simian immunodeficiency virus by cynomolgus macaque monkeys immunized with recombinant vaccinia virus.
par: Gotch, F, et autres
Publié: (1991)

Cytotoxic T-cell recognition of HIV proteins and peptides.
par: Nixon, D, et autres
Publié: (1991)

Safety and tolerability of recombinant modified vaccinia virus Ankara expressing an HIV-1 gag/multiepitope immunogen (MVA.HIVA) in HIV-1-infected persons receiving combination antiretroviral therapy.
par: Dorrell, L, et autres
Publié: (2007)

Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen.
par: Townsend, A, et autres
Publié: (1988)

Specificity of cytotoxic T lymphocytes stimulated with influenza virus. Studies in mice and humans.
par: Townsend, A, et autres
Publié: (1985)

Cytotoxic T lymphocytes recognize structurally diverse, clade-specific and cross-reactive peptides in human immunodeficiency virus type-1 gag through HLA-B53.
par: Dorrell, L, et autres
Publié: (2001)

Immunisation with recombinant modified vaccinia virus Ankara expressing HIV-1 gag in HIV-1-infected subjects stimulates broad functional CD4+ T cell responses.
par: Ondondo, B, et autres
Publié: (2006)

Recombinant vaccinia viruses for the characterization of Plasmodium falciparum-specific cytotoxic T lymphocytes: recognition of processed antigen despite limited re-stimulation efficacy.
par: Aidoo, M, et autres
Publié: (1997)

Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses
par: Kelleher, A, et autres
Publié: (2001)

Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses.
par: Kelleher, A, et autres
Publié: (2001)

Vaccinia virus serpins B13R and B22R do not inhibit antigen presentation to class I-restricted cytotoxic T lymphocytes.
par: Blake, N, et autres
Publié: (1995)

Identification of an immunodominant cytotoxic T-lymphocyte recognition site in glycoprotein B of herpes simplex virus by using recombinant adenovirus vectors and synthetic peptides.
par: Hanke, T, et autres
Publié: (1991)

Effect of mutations and variations of HLA-A2 on recognition of a virus peptide epitope by cytotoxic T lymphocytes.
par: Mcmichael, A, et autres
Publié: (1988)

Significance of the six peptide-binding pockets of HLA-A2.1 in influenza A matrix peptide-specific cytotoxic T-lymphocyte reactivity.
par: Matsui, M, et autres
Publié: (1994)

Cytotoxic T lymphocytes in HIV infection
par: Rowland-Jones, S, et autres
Publié: (1993)

Recognition of influenza virus proteins by cytotoxic T lymphocytes.
par: Townsend, A, et autres
Publié: (1989)

Recombinant Salmonella typhimurium strains that invade nonphagocytic cells are resistant to recognition by antigen-specific cytotoxic T lymphocytes.
par: Gao, X, et autres
Publié: (1992)

Identification of new HIV-1 Gag-specific cytotoxic T lymphocyte responses in BALB/c mice
par: Caputo Antonella, et autres
Publié: (2008-07-01)

Correction: Gag-Positive Reservoir Cells Are Susceptible to HIV-Specific Cytotoxic T Lymphocyte Mediated Clearance and Can Be Detected.
par: Erin H. Graf, et autres
Publié: (2013-01-01)

Expansion and diversification of virus-specific T cells following immunization of human immunodeficiency virus type 1 (HIV-1)-infected individuals with a recombinant modified vaccinia virus Ankara/HIV-1 Gag vaccine.
par: Dorrell, L, et autres
Publié: (2006)

Identification of a novel HLA-B*3501-restricted cytotoxic T lymphocyte epitope using overlapping peptides.
par: Goulder, P, et autres
Publié: (1997)

The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus.
par: Klenerman, P, et autres
Publié: (1995)

Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection.
par: Allen, T, et autres
Publié: (2002)

Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2.
par: Gotch, F, et autres
Publié: (1987)

Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogue.
par: Valmori, D, et autres
Publié: (2000)

Gag-positive reservoir cells are susceptible to HIV-specific cytotoxic T lymphocyte mediated clearance in vitro and can be detected in vivo [corrected].
par: Erin H Graf, et autres
Publié: (2013-01-01)

Recognition of influenza virus proteins by cytotoxic T lymphocytes.
par: Townsend, A
Publié: (1987)

In vivo targeting of protein antigens to dendritic cells using anti‐DEC‐205 single chain antibody improves HIV Gag specific CD4+ T cell responses protecting from airway challenge with recombinant vaccinia‐gag virus
par: Loveline N. Ngu, et autres
Publié: (2019-06-01)

Survivin-based recombinant overlapping peptides induce t lymphocyte cytotoxicity and prolong the survival in in vivo melanoma model
par: Zhang, Y, et autres
Publié: (2023)

Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen.
par: Hanke, T, et autres
Publié: (1999)

Recognition of influenza A virus by human cytotoxic T lymphocytes.
par: Mcmichael, A, et autres
Publié: (1989)

A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides.
par: Sutton, J, et autres
Publié: (1993)